Globe Life (NYSE:GL) Issues Quarterly Earnings Results, Misses Expectations By $0.06 EPS
by Doug Wharley · The Cerbat GemGlobe Life (NYSE:GL – Get Free Report) posted its quarterly earnings results on Wednesday. The company reported $3.43 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.49 by ($0.06), FiscalAI reports. The company had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.56 billion. Globe Life had a net margin of 19.37% and a return on equity of 21.30%. Globe Life updated its FY 2026 guidance to 15.400-15.90 EPS.
Globe Life Stock Performance
GL stock traded up $0.44 during trading on Wednesday, hitting $151.36. 568,844 shares of the company’s stock traded hands, compared to its average volume of 500,687. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.39. Globe Life has a 52 week low of $111.13 and a 52 week high of $152.80. The stock has a fifty day moving average price of $143.17 and a two-hundred day moving average price of $139.20. The stock has a market capitalization of $11.87 billion, a price-to-earnings ratio of 10.75 and a beta of 0.47.
Globe Life Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, May 1st. Shareholders of record on Friday, April 3rd will be paid a dividend of $0.33 per share. The ex-dividend date is Thursday, April 2nd. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. This represents a $1.32 annualized dividend and a yield of 0.9%. Globe Life’s payout ratio is presently 9.38%.
Analyst Ratings Changes
GL has been the topic of several recent analyst reports. Texas Capital raised shares of Globe Life to a “strong-buy” rating in a report on Wednesday, March 18th. Weiss Ratings upgraded shares of Globe Life from a “hold (c+)” rating to a “buy (b)” rating in a research note on Monday, April 13th. Evercore set a $157.00 target price on shares of Globe Life in a research note on Wednesday, February 18th. Wells Fargo & Company boosted their target price on shares of Globe Life from $171.00 to $172.00 and gave the company an “overweight” rating in a research note on Friday, April 10th. Finally, JPMorgan Chase & Co. boosted their target price on shares of Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $172.11.
Read Our Latest Stock Report on Globe Life
Insider Activity
In other news, CEO James Matthew Darden sold 18,318 shares of the business’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $145.10, for a total transaction of $2,657,941.80. Following the completion of the transaction, the chief executive officer owned 51,093 shares of the company’s stock, valued at approximately $7,413,594.30. The trade was a 26.39% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert Edward Hensley sold 712 shares of the business’s stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $142.59, for a total transaction of $101,524.08. Following the transaction, the executive vice president directly owned 8,580 shares of the company’s stock, valued at approximately $1,223,422.20. This trade represents a 7.66% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 82,807 shares of company stock valued at $12,041,286 over the last quarter. 2.11% of the stock is owned by company insiders.
Hedge Funds Weigh In On Globe Life
Several hedge funds and other institutional investors have recently modified their holdings of GL. AQR Capital Management LLC boosted its holdings in shares of Globe Life by 98.6% during the second quarter. AQR Capital Management LLC now owns 1,402,690 shares of the company’s stock valued at $174,340,000 after acquiring an additional 696,548 shares during the period. Balyasny Asset Management L.P. acquired a new position in shares of Globe Life during the third quarter valued at $80,925,000. Nuveen LLC boosted its holdings in shares of Globe Life by 20.4% during the fourth quarter. Nuveen LLC now owns 1,374,302 shares of the company’s stock valued at $192,210,000 after acquiring an additional 233,145 shares during the period. Comerica Bank boosted its holdings in shares of Globe Life by 865.4% during the third quarter. Comerica Bank now owns 152,662 shares of the company’s stock valued at $21,826,000 after acquiring an additional 136,849 shares during the period. Finally, Morgan Stanley boosted its holdings in shares of Globe Life by 7.2% during the fourth quarter. Morgan Stanley now owns 1,860,257 shares of the company’s stock valued at $260,176,000 after acquiring an additional 125,567 shares during the period. Institutional investors and hedge funds own 81.61% of the company’s stock.
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.